Top BRD4 inhibition by ABBV-744 in cancer research studies Secrets
In Phase C, contributors will obtain ABBV-744 and oral navitoclax. In Phase D, participants will get ABBV-744 and ruxolitinib. Participants will obtain treatment until eventually ailment progression or the individuals are unable to tolerate the study drugs.For all move cytometry experiments, 10,000 cells for every replicate ended up analyzed, and t